This is the first report of secondary resistance to rifampin following MDT in a patient with prolonged, but irregular treatment. Repeated mouse foot-pad studies demonstrated resistance to dapsone after several years of monotherapy, and following subsequent MDT the studies demonstrated the development of resistance to rifampin.
|Original language||English (US)|
|Number of pages||4|
|Journal||International Journal of Leprosy and Other Mycobacterial Diseases|
|State||Published - Mar 2003|
ASJC Scopus subject areas